Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > Natco Pharma launches Albupax for breast cancer treatment

September 19th, 2008

Natco Pharma launches Albupax for breast cancer treatment

Abstract:
Natco Pharma, the Hyderabad-based pharma company has launched Albupax, a nanotechnology drug for treatment of breast cancer.



Also Read

News Now

Paper

Specials
- Bulls Day Out: Sensex gains 727pts on global cues
- FIIs net buy Rs 1,016cr, DIIs net buy Rs 44cr
- PM holds second CCEA meeting to review the global financial situation
- Global markets rally; Hang Seng, Shanghai soar 9%
- ONGC to invest Rs 19,338 cr in oil & gas exploration
- PM to chair meeting on Integrated Energy Policy
More

Also Read

News Now

Paper

Specials

- Sensex rallies on FM-speak, global cues
- Tata Motors holds talks with Karnataka for alternative Nano site
- Government opens a new page for foreign news magazines
- Nasscom's $60 bn export target in jeopardy
- Ranbaxy appoints Giuliani firm to counter FDA ruling
More

Also Read

News Now

Paper

Specials

- Subprime Crisis: US faces economic turmoil
- Fighting Inflation : Inflation at a 13-year high
- Your Money : Personal finance
- Credit Policy : RBI's monetary policy review
- Tracking the downturn : Economic slowdown and its impact
- Time Out : food, travel, sports, health...
More

Over a lakh new incidences of breast cancer are reported in India every year.

Albupax has been indigenously developed by Natco in India. The company has priced each 100 milligram (mg) vial of the drug at Rs 11,500. The estimated domestic market for this product is around Rs 150 crore.

Source:
business-standard.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers demonstrates substrate design principles for scalable superconducting quantum materials: NYU Tandon–Brookhaven National Laboratory study shows that crystalline hafnium oxide substrates offer guidelines for stabilizing the superconducting phase October 3rd, 2025

Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025

Next-generation quantum communication October 3rd, 2025

"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025

Nanomedicine

New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025

New imaging approach transforms study of bacterial biofilms August 8th, 2025

Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025

Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025

Announcements

Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025

Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025

Next-generation quantum communication October 3rd, 2025

"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project